Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 1 of 1

Publication Record


A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.
Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N, Demeyer I, Sainati S, Amlot N, Cao C, Ii M, Matsuda H, Mouri K, Cohen J
(2010) Crit Care Med 38: 1685-94
MeSH Terms: Adult, Aged, Cytokines, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Hospital Mortality, Humans, Infusions, Intravenous, Male, Middle Aged, Multiple Organ Failure, Probability, Pulse Therapy, Drug, Reference Values, Risk Assessment, Sepsis, Sulfonamides, Survival Analysis, Treatment Outcome
Added March 5, 2014
0 Communities
1 Members
0 Resources
22 MeSH Terms